Stock Report

Windlas Biotech Q3FY22 consolidated PAT at Rs. 8.31 crore

Posted On : 2022-02-02 15:40:29( TIMEZONE : IST )

Windlas Biotech Ltd has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 119.384 crores during the period ended December 31, 2021 as compared to Rs. 116.471 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 8.314 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 8.30 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 3.81 for the period ended December 31, 2021 as compared to Rs. 4.10 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 119.384 crs	₹116.471 crs	2.50%
Net Profit	₹8.314 crs	₹8.30 crs	0.17%
EPS	₹3.81	₹4.10	-7.07%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 119.384 crores during the period ended December 31, 2021 as compared to Rs.118.183 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.8.314 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.12.282 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.3.81 for the period ended December 31, 2021 as compared to Rs.6.75 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 119.384 crs	₹118.183 crs	1.02%
Net Profit	₹8.314 crs	₹12.282 crs	-32.31%
EPS	₹3.81	₹6.75	-43.56%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.347.50 crores during the 9 Months period ended December 31, 2021 as compared to Rs.323.094 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.23.301 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.9.936 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.11.60 for the 9 Months period ended December 31, 2021 as compared to Rs.5.46 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹347.50 crs	₹323.094 crs	7.55%
Net Profit	₹23.301 crs	₹9.936 crs	134.51%
EPS	₹11.60	₹5.46	112.45%

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 261.25 as compared to the previous close of Rs. 260.60. The total number of shares traded during the day was 5012 in over 417 trades.

The stock hit an intraday high of Rs. 264.90 and intraday low of 259.00. The net turnover during the day was Rs. 1308749.00.